78%
MagnetOs Granules
78.0% (39/50)
Autograft
42.0% (21/50)
42%
PROMO/MAG/US/015-22/R00
Reference: 1. Data on File.
Manufactured by Kuros Biosciences BV
Prof Bronkhorstlaan 10, Building 48, 3723 MB Bilthoven, The Netherlands.
kurosbio.com
MagnetOs is a trademark of Kuros Biosciences.
MagnetOs Granules achieved a fusion rate of 78% (39/50 subjects)
compared to 42.0% (21/50 subjects) for autograft.
So, would you like to know all the
details of this clinical study?
Visit our website to download the full Preliminary Analysis of
Ongoing Prospective Data from this trial – and view the
Animated Abstract.
Fusion rate by CT after one year:
(% subjects)
